Additionally, by analyzing RNA sequencing data in the CCLE (Cancer Cell Line Encyclopedia) [58] database, we confirmed that c-Myc target and OXPHOS-related genes are highly upregulated in vemurafenib-resistant cell lines (Fig. S8D). The gene discussed is MYC; the disease is cancer.